leadf
logo-loader
viewBlue Star Capital PLC

Proactive Research Analyst Ed Stacey talks Blue Star Capital

Ed Stacey's new initiation report on Blue Star Capital (LON:BLU) is out and here Proactive's research guru goes through all the details.

Thoughts from Stacey here on Blue Star's current portfolio including their most recent acquisition ESports plus their other interests.

Stacey also talks investors through the upsides and offers advice on whether or not they're properly reflected in the valuation.

Click here to read Ed Stacey's initiation note on Blue Star Capital

Quick facts: Blue Star Capital PLC

Price: 0.1613 GBX

AIM:BLU
Market: AIM
Market Cap: £6.98 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Tetra Bio-Pharma completes toxicology studies on coronavirus candidate,...

Tetra Bio-Pharma Inc (TSE:TBP) (OTCQB:TBPMF) CEO Guy Chamberland tells Proactive it has completed toxicology studies on its coronavirus drug candidate ARDS-003, clearing the path for human clinical trials. Chamberland says next steps include structuring the applications to begin in-human...

22 minutes ago

2 min read